Large-scale (Phase III) evaluation of broflanilide 50WP (VECTRON™ T500) for indoor residual spraying for malaria vector control in Northeast Tanzania: study protocol for a two-arm, non-inferiority, cluster-randomised community trial

Peer Review reports

Original Submission
26 Jan 2022	Submitted	Original manuscript
4 Feb 2022	Author responded	Author comments - Patrick K Tungu
Resubmission - Version 2
4 Feb 2022	Submitted	Manuscript version 2
Publishing
9 Feb 2022	Editorially accepted
21 Feb 2022	Article published	10.1186/s12879-022-07138-3

Back to article page